S 1936 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Improving Access to Transfusion Care for Hospice Patients Act of 2025
To require the Center for Medicare and Medicaid Innovation to test allowing blood transfusions to be paid separately from the Medicare hospice all-inclusive per diem payment.
Summary
This bill directs the Center for Medicare and Medicaid Innovation to create and test a model allowing blood transfusions for hospice patients to be paid separately from the standard hospice per diem payment. Under the model, transfusions would be reimbursed at the standard Medicare rate rather than being included in the bundled hospice payment. The bill requires the agency to evaluate the model by comparing outcomes of hospice patients receiving transfusions under the new arrangement with similar patients outside the model, tracking metrics such as hospital utilization, length of hospice care, and transfusion frequency. The model must be established within one year of enactment.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Sen. Rosen, Jacky [D-NV] (D-NV)
2 cosponsors
- Sen. Baldwin, Tammy [D-WI] (D-WI)
- Sen. Barrasso, John [R-WY] (R-WY)
Actions (2)
- Jun 3, 2025 Read twice and referred to the Committee on Finance. · senate
- Jun 3, 2025 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE SENATE OF THE UNITED STATES
June 3, 2025
Ms. Rosen (for herself, Mr. Barrasso, and Ms. Baldwin) introduced the following bill; which was read twice and referred to the Committee on Finance
A BILL
To require the Center for Medicare and Medicaid Innovation to test allowing blood transfusions to be paid separately from the Medicare hospice all-inclusive per diem payment.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Improving Access to Transfusion Care for Hospice Patients Act of 2025”.
SEC. 2. CENTER FOR MEDICARE AND MEDICAID INNOVATION TESTING OF ALLOWING BLOOD TRANSFUSIONS TO BE PAID SEPARATELY FROM THE MEDICARE HOSPICE ALL-INCLUSIVE PER DIEM PAYMENT.
Section 1115A of the Social Security Act (42 U.S.C. 1315a) is amended—
(1) in subsection (b)(2)(A), by adding at the end the following new sentence: “The models selected under this subparagraph shall include the testing of the model described in subsection (h).”; and
(2) by adding at the end the following new subsection:
“(h) Testing of Allowing Blood Transfusions To Be Paid Separately From the Medicare Hospice All-Inclusive Per Diem Payment.—
“(1) In general.—Not later than 1 year after the date of enactment of this subsection, the CMI shall establish and implement a model under which blood transfusions furnished to an individual receiving hospice care are paid separately from the hospice all-inclusive per diem payment under section 1814(i). The separate payment amount for such blood transfusion shall be the amount that would otherwise apply under title XVIII if the transfusion was not furnished as part of hospice care.
“(2) Requirements for evaluation.—In conducting any evaluation of the model described in paragraph (1) pursuant to subsection (b)(4), the CMI shall ensure it compares participants under the model with similar patients outside of the model with respect to the following metrics:
“(A) The number of chemotherapy services furnished in the last 14 days of life.
“(B) Hospital utilization in the last 30 days of life, including emergency department visits, in-patient and observation status stays (including the length of the stays), and intensive care unit (ICU) days.
“(C) How many days receiving hospice care before the end of life.
“(D) The number of patients receiving hospice care who received a transfusion compared to patients with similar diagnoses not receiving hospice care.
“(E) The average frequency of transfusion for patients receiving hospice care compared to patients not receiving hospice care.
“(F) The number of transfusions for patients receiving hospice care compared to patients not receiving hospice care.
“(G) Other areas determined appropriate by the CMI.”. <all>
Comments